4th Annual Psychedelic Therapeutics & Drug Development Conference
May 23 - May 24
The 4th Annual Psychedelic Therapeutics and Drug Development Conference has been organized to bring together researchers and leaders in academia, industry, the nonprofit sector and government to discuss the challenges and opportunities facing those engaged in the research and development of psychedelics for various health conditions with considerable unmet need. The event will highlight the progress being made toward regulatory approval of a variety of psychedelics with the potential to treat various conditions, including inflammatory/autoimmune disorders, brain injury, pain, PTSD, anxiety, ADHD, headaches, depression and opioid-use disorder.
Speakers and panelists will cover topics such as Clinical-Trial Design, Intellectual Property, Regulatory Guidance, Psychedelic-Drug Delivery, Commercialization, Legal Issues, Emerging Preclinical Science and New Clinical Data.
The 4th Annual Psychedelic Therapeutics and Drug Development Conference has been organized to bring together researchers and leaders in academia, industry, the nonprofit sector and government to discuss the challenges and opportunities facing those engaged in the research and development of psychedelics for various health conditions with considerable unmet need. The event will highlight the progress being made toward regulatory approval of a variety of psychedelics with the potential to treat various conditions, including inflammatory/autoimmune disorders, brain injury, pain, PTSD, anxiety, ADHD, headaches, depression and opioid-use disorder.
Speakers and panelists will cover topics such as Clinical-Trial Design, Intellectual Property, Regulatory Guidance, Psychedelic-Drug Delivery, Commercialization, Legal Issues, Emerging Preclinical Science and New Clinical Data.
Details
Organizer
Venue
Boston, MA 02116 United States + Google Map